bpc-157 human clinical trials 2025 2026 International Day 2026: inside First-in-Human trials FDA panel votes to place

Circulating Exosomal MicroRNA profiles associated with acute soft tissue injury

Singh, A

Ingredients Aqua (Water), Butyrospermum Parkii (Shea) Butter, Glycerin, Cetearyl Alcohol, Parfum (Fragrance), Glyceryl Stearate, Peg -100 Stearate, Phenoxyethanol, Dimethicone, Argania Spinosa (Argan) Kernel Oil, Polyacrylamide, Panthenol, Tocopheryl Acetate, Cocos Nucifera (Coconut ) Oil, Caprylyl Glycol, C13-14 Isoparaffin, Laminaria Digitata Extract, Fucus Vesiculosus Extract, Laureth-7, Maris Sal, Potassium Sorbate, Sodium Benzoate, Limonene, Linalool, Citronellol, Geraniol, Eugenol, Alpha-Isomethyl Ionone, Citral, Benzyl Salicylate

Many patients notice improvement within 1-2 weeks, particularly reduced pain and improved mobility at injury sites

Long-term human safety data does not yet exist